BAMF Health operates a vertically integrated theranostics center utilizing advanced molecular imaging and radiopharmaceutical therapy to detect and treat cancer, Alzheimer’s Disease, and heart conditions. The center provides personalized treatment plans based on individual patient responses, enhancing diagnostic accuracy and therapeutic effectiveness through state-of-the-art imaging technology.
Funding
Funding not disclosed
PVWYFounders
Product
Problem
Traditional methods for detecting and treating diseases like cancer, Alzheimer’s, and heart conditions often lack the precision needed for personalized treatment plans. Standard imaging techniques may miss subtle indicators, and therapies may not be tailored to individual patient responses, leading to suboptimal outcomes.
Solution
BAMF Health operates a vertically integrated theranostics center that leverages advanced molecular imaging and radiopharmaceutical therapy to provide personalized treatment. The center utilizes cutting-edge imaging technology, including total-body PET/CT scanners with increased resolution and sensitivity, to enhance diagnostic accuracy. Treatment plans are customized based on individual patient responses, with clinicians adjusting therapies to optimize effectiveness. The integration of AI algorithms further improves diagnosis and treatment strategies, offering a precision medicine approach.
Target Audience
The primary audience includes patients with cancer, Alzheimer’s Disease, and heart conditions, as well as healthcare providers seeking advanced diagnostic and therapeutic solutions.
Features
- Total-body PET/CT scanner with 2x the resolution and 40x more sensitivity than traditional scanners
- GE Starguide™ SPECT/CT scanner for assessing tumor uptake 24 hours post-therapy
- Adjacency of PET/MR to PET/CT for same-day imaging, enabling more accurate diagnosis
- AI-driven algorithms for improved patient diagnosis and treatment planning
- Personalized treatment plans adjusted based on individual patient responses to therapy